BR112014016347A2 - uso de uma composição; composição nutricional; e suplemento à base de glutamina na forma de um pó em uma dose unitária - Google Patents

uso de uma composição; composição nutricional; e suplemento à base de glutamina na forma de um pó em uma dose unitária

Info

Publication number
BR112014016347A2
BR112014016347A2 BR112014016347A BR112014016347A BR112014016347A2 BR 112014016347 A2 BR112014016347 A2 BR 112014016347A2 BR 112014016347 A BR112014016347 A BR 112014016347A BR 112014016347 A BR112014016347 A BR 112014016347A BR 112014016347 A2 BR112014016347 A2 BR 112014016347A2
Authority
BR
Brazil
Prior art keywords
composition
unit dose
powder
glutamine
glutamine supplement
Prior art date
Application number
BR112014016347A
Other languages
English (en)
Other versions
BR112014016347A8 (pt
BR112014016347B1 (pt
Inventor
Boehm Günther
Matthijs Van Elburg Roelof
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47710263&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112014016347(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of BR112014016347A2 publication Critical patent/BR112014016347A2/pt
Publication of BR112014016347A8 publication Critical patent/BR112014016347A8/pt
Publication of BR112014016347B1 publication Critical patent/BR112014016347B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Pediatric Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

resumo uso de uma composição; composição nutricional; e suplemento à base de glutamina na forma de um pó em uma dose unitária a presente invenção se refere ao uso de composições nutricionais enriquecidas em glutamina para melhorar o desenvolvimento cerebral estrutural em bebês prematuros e/ou com baixo peso ao nascimento. 1/1
BR112014016347A 2012-01-09 2013-01-09 uso de uma composição; composição nutricional; e suplemento à base de glutamina na forma de um pó em uma dose unitária BR112014016347B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12150499.7A EP2612560A1 (en) 2012-01-09 2012-01-09 Glutamine enriched nutritional composition for preterm infants
PCT/NL2013/050008 WO2013105852A1 (en) 2012-01-09 2013-01-09 Glutamine enriched nutritional composition for preterm infants

Publications (3)

Publication Number Publication Date
BR112014016347A2 true BR112014016347A2 (pt) 2017-06-13
BR112014016347A8 BR112014016347A8 (pt) 2017-07-04
BR112014016347B1 BR112014016347B1 (pt) 2020-02-04

Family

ID=47710263

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014016347A BR112014016347B1 (pt) 2012-01-09 2013-01-09 uso de uma composição; composição nutricional; e suplemento à base de glutamina na forma de um pó em uma dose unitária

Country Status (12)

Country Link
US (1) US20150024082A1 (pt)
EP (3) EP2612560A1 (pt)
CN (2) CN104039172B (pt)
AU (2) AU2013208360B2 (pt)
BR (1) BR112014016347B1 (pt)
ES (1) ES2589916T3 (pt)
MY (1) MY172237A (pt)
NZ (1) NZ626573A (pt)
PH (1) PH12014501569A1 (pt)
PL (1) PL2802222T3 (pt)
RU (1) RU2614588C2 (pt)
WO (1) WO2013105852A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140057014A1 (en) * 2012-08-27 2014-02-27 Carol Lynn Berseth Formula Fortifier
WO2018143793A1 (en) * 2017-02-01 2018-08-09 N.V. Nutricia Dietary modulation of brain functioning

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94549A (en) 1989-06-02 1996-08-04 Brigham & Womens Hospital A pharmaceutical preparation containing glutamine
US5438042B1 (en) * 1993-10-08 1997-08-26 Sandoz Nutrition Ltd Enteral nutritional composition having amino acid profile
US6001878A (en) * 1994-01-11 1999-12-14 Van Leeuwen; Paulus Aloisius Marie Method of treating disorders of the animal or human body by administering amino acids
NL9400418A (nl) * 1994-03-16 1995-11-01 Campina Melkunie Bv Werkwijzen voor de bereiding van glutaminerijke peptiden en voedingspreparaten daarmee gemaakt.
JP2001128615A (ja) 1999-11-04 2001-05-15 Ajinomoto Co Inc 乳幼児用調整粉乳
US6511696B2 (en) * 2000-12-13 2003-01-28 Novartis Nutrition Ag Infant formula with free amino acids and nucleotides
AU2002356547A1 (en) * 2002-10-08 2004-05-04 Abbott Laboratories Methods and compositions for providing glutamine
CN1505977A (zh) * 2002-12-10 2004-06-23 信东生技股份有限公司 营养组成物
WO2005030243A1 (en) * 2003-09-26 2005-04-07 Bristol Myers Squibb Company Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation
BRPI0403861A (pt) * 2004-08-30 2005-08-02 Rn Ct Produtos E Servicos Farm Composição para suplemento ao leite materno
RU2398445C2 (ru) * 2005-06-09 2010-09-10 Хилл`С Пет Ньютришн, Инк. Композиция и способ обеспечения глютамина
US8287931B2 (en) * 2005-06-30 2012-10-16 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
RU2375923C2 (ru) * 2008-01-18 2009-12-20 ЗАО "Академия-Т" Специализированный белковый продукт для питания спортсменов
US20110086809A1 (en) * 2009-10-14 2011-04-14 Joshua Anthony Enteral Administration Of Arginine-Glutamine Dipeptide To Support Retinal, Intestinal, Or Nervous System Development
US20110208153A1 (en) * 2010-02-24 2011-08-25 John Alvey Formulations and methods for nutrient delivery

Also Published As

Publication number Publication date
EP3120715A1 (en) 2017-01-25
WO2013105852A1 (en) 2013-07-18
EP2802222B1 (en) 2016-06-15
RU2014132852A (ru) 2016-02-27
BR112014016347A8 (pt) 2017-07-04
CN106617003A (zh) 2017-05-10
US20150024082A1 (en) 2015-01-22
AU2016238962B2 (en) 2018-02-15
CN104039172A (zh) 2014-09-10
BR112014016347B1 (pt) 2020-02-04
EP2612560A1 (en) 2013-07-10
PH12014501569A1 (en) 2014-10-08
PL2802222T3 (pl) 2016-12-30
ES2589916T3 (es) 2016-11-17
CN104039172B (zh) 2017-02-22
AU2013208360B2 (en) 2016-10-20
EP2802222A1 (en) 2014-11-19
RU2614588C2 (ru) 2017-03-28
AU2016238962A1 (en) 2016-11-03
MY172237A (en) 2019-11-18
NZ626573A (en) 2016-10-28
AU2013208360A1 (en) 2014-07-10

Similar Documents

Publication Publication Date Title
BR112017007375A2 (pt) composição compreendendo oligossa¬carídeos fut2 dependentes e lacto-n-neotetraose para uso na promoção do desenvolvimento e da cognição cerebral
BR112017008720A2 (pt) métodos e composições relacionados a nanoveículos sintéticos com rapamicina em um estado supersaturado, estável
BR112014003640A8 (pt) métodos para perda de peso e composições cetogênicas
BR112015024647A2 (pt) fórmula para bebês com um baixo teor de mcfas em proporções específicas e um teor relativamente alto de ácidos graxos insaturados, e seu uso na promoção do estabelecimento saudável da função cognitiva em bebês
BR112015000615A8 (pt) Purinas macrocíclicas para o tratamento de infecções virais e composição farmacêutica que as compreende
BR112012010130A2 (pt) Composições nutricionais compreendendo lactoferrina e probióticos, e kits de partes das mesmas
BR112014008944A2 (pt) composição para uso no crescimento cerebral e/ou desenvolvimento cognitivo e/ou psicomotor
BR112014010290B8 (pt) Composição farmacêutica na forma de dispersão sólida de ativos específicos em polímeros específicos e uso da composição farmacêutica
BR112013029269A8 (pt) combinação farmacêutica para uso na indução de perda de peso em pacientes com diabetes tipo 2 e/ou para prevenir o ganho de peso em pacientes com diabetes tipo 2
BR112015011430A2 (pt) composição para liberação imediata e prolongada
BR112014005025A2 (pt) composição farmacêutica para uso no tratamento de uma doença neurodegenerativa
IN2013DN03771A (pt)
BR112014027047A2 (pt) nova formulação
BR112015015137A2 (pt) estrutura à base de polietileno
BR112015027824A8 (pt) formulação de vitamina e na forma de pó
BR112015008170A2 (pt) cristal mono-hidratado de sal de potássio fimasartana, método para a preparação do mesmo e composição farmacológica compreendendo o mesmo
BR112014016346A2 (pt) uso de glutamina ou de uma composição
BR112013028820A2 (pt) alimento medicinal para declínio cognitivo
BR112012013574A2 (pt) sistema de distribuição de fórmula infantil compreendendo probióticos e uma formuação nutricional infantil
BR112015011759A2 (pt) composição simbiótica e uso da mesma
BR112017001097A2 (pt) mioinositol e probióticos e seu uso
BR112014016347A2 (pt) uso de uma composição; composição nutricional; e suplemento à base de glutamina na forma de um pó em uma dose unitária
BR112015014137B8 (pt) Composição com alto teor de fexofenadina e processo para a preparação da mesma
BR112014007829A2 (pt) composição para uso na promoção de absorção de magnésio e/ou retenção de magnésio
BR112017010690A2 (pt) nutrição para bebês com proteína hidrolisada, cálcio iônico e ácido palmítico

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A23L 1/29 , A23L 1/305 , A61K 31/198

Ipc: A23L 33/175 (2016.01), A61K 31/198 (2000.01)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/01/2013, OBSERVADAS AS CONDICOES LEGAIS.